Business Wire

Megaport Announces Strategic Partnership With Bechtle as Network as a Service (NaaS) Vendor Partner

Share

Megaport Limited (ASX: MP1) ("Megaport"), a global leading Network as a Service (NaaS) provider, announced it has entered into a distribution agreement with Bechtle, Germany’s largest IT system house and a leading IT e-commerce provider in Europe. The agreement will make Megaport’s global, private Software Defined Network (SDN) platform available through Bechtle to companies looking to modernise their networks and accelerate digital transformation.

“Bringing Megaport’s leading NaaS platform into the Bechtle portfolio makes it easier for customers to modernise their network connectivity and connect quickly to leading cloud service providers,” said Rodney Foreman, Chief Revenue Officer at Megaport. “Whether customers are addressing multicloud architectures, bridging SD-WAN to cloud, or enabling hybrid environments, Megaport’s platform makes it easy to securely and rapidly connect critical IT services. Bechtle’s European footprint and reach, combined with their expertise in IT solutions, makes them ideal to expand and deepen our channel relationships.”

“With Megaport, we are expanding our portfolio with innovative and scalable IaaS-solutions that are required by today’s competitive companies,” explained Ralf Beck, Director Software Product Management Infrastructure at Bechtle. “The provision of services by German data centres and the connectivity to leading cloud providers round off Megaport’s range of service.”

By using Megaport, Bechtle customers can enjoy the following benefits:

  • Improved network performance with reduced jitter and latency.
  • Reduced cloud egress costs to cloud on-ramps when compared to internet rates.
  • Point-and-click network provisioning to support interconnection between branch locations, data centres, cloud providers, and IT services without any hardware requirements.
  • Real-time provisioning of virtual network infrastructure and interconnections.
  • Secure, private hybrid cloud and multicloud connections to more than 360 service providers, 750+ enabled data centres, and 240+ cloud interconnect points.

With more than 80 IT system houses in Germany, Austria, and Switzerland as well as e-commerce companies in 14 European countries, Bechtle offers a blend of direct IT product sales and extensive systems integration services to midsized business, large corporations, and public-sector organisations. Backed by extensive experience and expertise in future-proof IT architecture, Bechtle values traditional infrastructures as well as current trends in digitalisation, cloud computing, modern workplace, security, and IT-as-a-Service.

Megaport helps businesses deploy a global, high-availability network in minutes, not months. Megaport’s NaaS platform provides private, scalable, on-demand connectivity to the world’s leading cloud service providers, such as AWS, Microsoft Azure, and Google Cloud. The company’s solutions enable agile, flexible, high-performance networking for a fraction of the cost of traditional methods.

About Megaport

Megaport is a leading provider of Network as a Service (NaaS) solutions. The company’s global Software Defined Network (SDN) helps businesses rapidly connect their network to services via an easy-to-use portal or our open API. Megaport offers agile networking capabilities that reduce operating costs and increase speed to market compared to traditional networking solutions. Megaport partners with the world’s top cloud service providers, including AWS, Microsoft Azure, and Google Cloud, as well as the largest data centre operators, systems integrators and managed service providers in the world. Megaport is an ISO/IEC 27001-certified company.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Eric Troyer, Chief Marketing Officer, Megaport
Phone: +61 7 3088 7400
media@megaport.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ipsen: ASCO 2022: New Cabometyx ® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer26.5.2022 23:00:00 CEST | Press release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced encouraging data to be presented for the multi-targeted tyrosine kinase inhibitor (TKI), Cabometyx® (cabozantinib), across a range of cancer types at this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2022) to be held on 3-7 June. Data presentations will include findings in metastatic non-small cell lung cancer (NSCLC), as well as established indications of advanced renal cell carcinoma and radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). These data show that the therapeutic potential of Cabometyx as a key treatment option in a broad range of tumors is continuing to be realized. Updated outcomes from the multicenter Phase Ib COSMIC-021 trial evaluating the combination of Cabometyx plus atezolizumab in an expanded patient population in metastatic NSCLC demonstrate encouraging clinical activity with manageable toxicity in people previously treated with an immune checkpoint inhib

New Better Dispensing Videos from Nordson EFD Explain Jetting Technology and How to Choose the Right Solution26.5.2022 19:00:00 CEST | Press release

Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces a new Better Dispensing™ How-To Video series. These three highly educational videos presented by EFD application specialist, Tom Muccino, provide best practices for choosing between contact dispensing and non-contact (jet) dispensing, and how to select the best jetting valve for a manufacturing application. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510006079/en/ xQR41 Series MicroDot™ needle valve (left) and PICO Pµlse XP jet valve (right). (Photo: Business Wire) “One of the main differences is that with jetting, your valve never touches the surface of the part. Instead, your fluid “flies” or “jets” out of the valve, which is above the part,” Muccino explains in the first video. “This makes jetting perfect for fragile or complex parts.” Nordson EFD provides a wide range of contact and non-contact (jet

Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA26.5.2022 18:17:00 CEST | Press release

On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio). “Partnering with Deebio in June 2021 was a huge milestone for the pharmaceutical compounding industry as it allowed us to secure and stabilize the supply of high quality Thyroid Powder for the US market,” said Panagiota Danopoulos, Senior Vice President of Global Strategy & Innovation at Medisca. “After going to market, we immediately realized that the demand for Thyroid Powder extended outside of our usual distribution channels to compounding pharmacies,” continued Danopoulos. “And we had the capacity to upscale supply to make this critical ingredient accessible to various markets, chan

Merck to Present Latest Research From Oncology Portfolio at ASCO 202226.5.2022 18:00:00 CEST | Press release

Merck, a leading science and technology company, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7, 2022. Data encompass Company-sponsored, investigator-sponsored, and external collaboration studies. Abstracts to be shared at the meeting include data for the Company’s licensed medicines BAVENCIO® (avelumab), TEPMETKO® (tepotinib) and ERBITUX® (cetuximab), and its oncology pipeline. The presentations span key tumor types including advanced urothelial carcinoma (UC), advanced renal cell carcinoma (RCC), metastatic non-small cell lung cancer (NSCLC), metastatic colorectal cancer (CRC), and head and neck cancer (SCCHN). “We look forward to coming together with the scientific community at ASCO 2022, where we will share the latest data from our portfolio, which demonstrate our determination to make a real difference in the lives of

Trading Central wins at the Technical Analyst Awards26.5.2022 17:30:00 CEST | Press release

The Technical Analyst Awards recognize the best in market research, financial data, software and artificial intelligence. At the 2022 edition, industry peers voted Trading Central a winner in three categories: Best AI Product, Most Innovative New Product & Best Multi-Asset Data Provider. Trading Central’s suite of embeddable apps & APIs power the world’s leading online broker platforms to support investors and active traders throughout their decision making journey. We’re proud to be recognized for our relentless efforts to challenge ourselves, innovate and disrupt the industry. TC Market Buzz® for Best AI Product Read less, know more TC Market Buzz leverages Artificial Intelligence to make sense of the millions of news headlines, social media posts and articles posted online every day. It replaces static headlines with simple, compelling and informative data visualizations. Users can: Identify what instruments are buzzing based on news volume View the most discussed topics for an inst